The proportions of antitumor immune cells (CD14+ monocytes, M1 macrophages, DCs, and CD8+ T cells) increased, but the tumor‐associated immune cells (M2‐like macrophages) decreased (Figure 2D). The gene discussed is CD14; the disease is neoplasm.